banner

product

99% Cetilistat CAS No 282526-98-1

Short Description:

Assay:≥ 99%

Packaging Details 1.0kg/Al-foil bag, 5.0 kgs/Al-foil bag, 25.0 kgs/drum ,inner by double plastic bag. or based on customers’ request

Storage: Stored in a cool&dry well-closed container, keep away from moisture and strong light/heat.

Shelf life: Two years under well storage situation

Product description:

1、Best Weight Lose Raw Steroid Powder

2、Strongest product in the company

3、Long-term large stock

4、Best quality and competitive price


Product Detail

Product Tags

Product Description

Name: Cetilistat

Appearance: Off-white cryst.

CAS No.: 282526-98-1

Density: 1.027 g/cm3

Formula: C25H39NO3

Boiling Point: 509.671 °C at 760 mmHg

Molecular Weight: 401.58

Flash Point: 158.925 °C

Synonyms: 2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one

The Cetilistat is an organic compound with the formula C25H39NO3. The IUPAC name of this chemical is 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one. With the CAS registry number 282526-98-1, it is also named as 4H-3,1-benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-. The product's classification code is Treatment of obesity. Besides, it is a drug designed to treat obesity. It acts in the same way as the older drug orlistat by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.

Function

Cetilistat is a drug designed to treat obesity. It acts in the same way as the older drug orlistat(Xenical) by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.

Application

In human trials, cetilistat was shown to produce similar weight loss to orlistat, but also produced similar side effects such as oily, loose stools, fecal incontinence, frequent bowel movements, andflatulence.It is likely that the same precautions would apply in that absorption of fat-soluble vitamins and other fat-soluble nutrients may be inhibited, requiring vitamin supplements to be used to avoid deficiencies

Specification

Perform standard:Enterprise Standard
ITEM OF ANALYSIS STANDARD
Appearance White to brown powder
Identification Conforms
water ≤0.5%
Solvent residue Acetone ≤5000ppm
Acetonitrile≤410ppm
Heavy metals ≤20ppm
HPLC ≥99.0%
Single impurity ≤0.2%
Residue on Ignition ≤0.2%
Conclusion Conforms to Enterprise Standard

  • Previous:
  • Next:

  • Write your message here and send it to us